ABOUT
ClinActis Pte Ltd is a full service CRO providing clinical trial services to the pharmaceutical, medical device, medical nutrition and biotech companies in Asia Pacific. Established in 2009, ClinActis Pte Ltd is headquartered in Singapore.
ABOUT US
ClinActis is a leading full-service contract research organization (CRO) providing clinical trial services in the Asia Pacific region to biotech, pharmaceutical, medical device, and medical nutrition companies.
About
_2_edited.png)
Established in 2009, ClinActis is a regional, full-service clinical research organization (CRO). Headquartered in Singapore, we are exclusively focused on providing clinical trial services in the Asia Pacific (APAC) region.
Our experienced team of clinical trial professionals have extensive experience working on global and multi-region clinical trials and a deep understanding of the local cultures, regulations, and healthcare systems in the APAC region. This enables us to efficiently deliver customized clinical trial services and solutions that meet clinical trial quality standards of major regulatory bodies like the USFDA and EMA, while also adhering to the unique guidelines and regulations of each country in the region.
As a full-service CRO, we offer a comprehensive range of clinical trial services and solutions, from strategic feasibility to study startup, management and close-out. Our goal is to provide our clients with a seamless and efficient clinical trial experience in APAC, from start to finish.
At ClinActis, we are dedicated to helping our clients bring safe, effective drugs and interventions to the market.
Experience
50+ years
of cumulative experience in clinical research in pharmaceutical and biotechnology companies as well as CROs.
Experience in Asia Pacific: Australia,
New Zealand, China, Malaysia, Hong Kong, India, Indonesia, the Philippines, Singapore, South Korea, Taiwan, Thailand, Japan and Vietnam.
Extensive knowledge of local regulatory frameworks, leading KOLs and highest-recruiting sites across the region.
Vast therapeutic experience in areas such as Oncology, Cardiovascular, Central Nervous System, Endocrinology, Infectious diseases, and Respiratory conditions.
Value Proposition
ClinActis is exclusively focused on delivering high-quality clinical research services in the APAC region. Our unique value proposition is our team’s global and multi-region clinical trial experience combined with its deep knowledge of local sites, PIs, KOLs and regulatory systems across the region. This enables us to provide efficient and effective services in APAC that comply with the most stringent international quality standards.
We believe that building a team with both global knowledge and local expertise is key to delivering high-quality clinical research services in the Asia Pacific region. Our team members have extensive experience working on regional and global, FDA/EMA-approved clinical trials, and are also experts in navigating the regulatory, operational, and cultural complexities of conducting clinical research across the APAC region.
Whether planning a local, multi-region, or global clinical trial, ClinActis' expertise and experience can ensure that sponsors find the highest-recruiting, most quality-driven clinical sites in APAC, ensuring that the trial remains on time, on budget, and is conducted to the highest levels of quality and safety possible.
Quality
ClinActis is committed to implement international standards to clinical trials. Our ability to deliver high quality results to our clients is based on recruiting and maintaining the best talents within our organization. Our senior management is fully accountable for the quality of deliverables to our clients.
Cost Effective Solutions
ClinActis is able to provide fair and cost effective solutions to our clients. As a regional CRO, we have a streamlined but effective organization that minimizes overhead, enabling country-specific rates. These translate to savings in terms of cost for our clients. Moreover, our knowledge of the region allows us to provide realistic and reasonable budgets upfront to our clients and minimize subsequent budget changes during the study.